Lento Bio, Inc.
PrivateLast Round
Seed
May 30, 2023
Total Funding Raised
$3.58M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lento Bio, Inc. operates in Healthcare & Life Sciences and is based in Syracuse, New York. Its latest recorded funding round was a Seed round in May 2023.
Lento Bio, Inc. is a biotechnology company developing small-molecule eyedrops to treat presbyopia by restoring ocular lens flexibility.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lento Bio, Inc. Comparables
Compare Lento Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glaukos Corporation | 74% | |
| Novartis | 73% | |
| Orasis Pharmaceuticals | 70% |
For institutional investors. Book with your work email.
Lento Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 30, 2023 | ||||
| Pre Seed | Sep 6, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lento Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Excell Partners | Seed |
| Richmond View Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 147% MoM, reaching 1.5K.
- Aug 20, 2026
Monthly visitors grew 796% MoM, from 68 to 609.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 5, 2026
Lento Bio, Inc. will present updates on its lead program, LB-01, at Eyecelerator @ American Academy of Ophthalmology (AAO) 2026 in Louisiana on Oct 8th '26.
For institutional investors. Book with your work email.
Lento Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lento Bio, Inc.'s valuation, stock price, and market status.
Is Lento Bio, Inc. a public or private company?
Lento Bio, Inc. is a private company.
What is the current stock price of Lento Bio, Inc.?
Lento Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Lento Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lento Bio, Inc. worth (valuation)?
Valuation information for Lento Bio, Inc. is not publicly available.
Can I buy Lento Bio, Inc. stock?
Lento Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lento Bio, Inc.'s last funding round?
Lento Bio, Inc.'s most recent funding round was Seed on May 30, 2023.
Who are the main investors in Lento Bio, Inc.?
Key investors in Lento Bio, Inc. include Excell Partners, Richmond View Ventures.
Will Lento Bio, Inc. IPO soon?
No public IPO plans have been announced for Lento Bio, Inc..
How can I track Lento Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Lento Bio, Inc.'s shares on secondary markets.